Machine Learning Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19… AIT News Desk May 27, 2022 Insilico's candidate demonstrated a favorable profile with good in vivo efficacy at low doses, efficient synthesis, and no need for…
Life Sciences Merck KGaA, Darmstadt, Germany to Deploy Insilico Medicine’s Chemistry42 AI Platform for… AIT News Desk Nov 27, 2020 Insilico Medicine announces the first deployment of its flagship generative chemistry AI platform for de novo molecular design, Chemistry42 on Merck…